- Home
- ABLV vs SRTS Comparison
ABLV vs SRTS Comparison
Compare ABLV & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- SRTS
- Stock Information
- Founded
- ABLV 2015
- SRTS 2010
- Country
- ABLV China
- SRTS United States
- Employees
- ABLV N/A
- SRTS N/A
- Industry
- ABLV
- SRTS Medical/Dental Instruments
- Sector
- ABLV
- SRTS Health Care
- Exchange
- ABLV Nasdaq
- SRTS Nasdaq
- Market Cap
- ABLV 51.4M
- SRTS 52.9M
- IPO Year
- ABLV N/A
- SRTS 2016
- Fundamental
- Price
- ABLV $0.92
- SRTS $3.19
- Analyst Decision
- ABLV
- SRTS Strong Buy
- Analyst Count
- ABLV 0
- SRTS 3
- Target Price
- ABLV N/A
- SRTS $8.00
- AVG Volume (30 Days)
- ABLV 20.0K
- SRTS 76.4K
- Earning Date
- ABLV 12-19-2025
- SRTS 11-06-2025
- Dividend Yield
- ABLV N/A
- SRTS N/A
- EPS Growth
- ABLV N/A
- SRTS N/A
- EPS
- ABLV 0.05
- SRTS N/A
- Revenue
- ABLV $114,319,869.00
- SRTS $37,564,000.00
- Revenue This Year
- ABLV N/A
- SRTS N/A
- Revenue Next Year
- ABLV N/A
- SRTS $47.33
- P/E Ratio
- ABLV $19.45
- SRTS N/A
- Revenue Growth
- ABLV N/A
- SRTS 3.29
- 52 Week Low
- ABLV $0.55
- SRTS $3.03
- 52 Week High
- ABLV $1.77
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- ABLV 46.13
- SRTS 44.23
- Support Level
- ABLV $0.88
- SRTS $3.13
- Resistance Level
- ABLV $0.98
- SRTS $3.45
- Average True Range (ATR)
- ABLV 0.07
- SRTS 0.17
- MACD
- ABLV -0.01
- SRTS -0.00
- Stochastic Oscillator
- ABLV 16.04
- SRTS 16.22
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.